BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 15184525)

  • 1. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
    Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.
    Bazuine M; Ouwens DM; Gomes de Mesquita DS; Maassen JA
    Eur J Biochem; 2003 Oct; 270(19):3891-903. PubMed ID: 14511371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.
    Wang YQ; Yao MH
    J Nutr Biochem; 2009 Dec; 20(12):982-91. PubMed ID: 19195868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation.
    Begum N; Ragolia L
    Am J Physiol Cell Physiol; 2000 Jan; 278(1):C81-91. PubMed ID: 10644515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
    Zhou Y; Ling EA; Dheen ST
    J Neurochem; 2007 Aug; 102(3):667-78. PubMed ID: 17403137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
    Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Diabetes; 2000 Oct; 49(10):1700-8. PubMed ID: 11016454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes.
    Harmon AW; Paul DS; Patel YM
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E758-66. PubMed ID: 15172888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.
    Lasa M; Abraham SM; Boucheron C; Saklatvala J; Clark AR
    Mol Cell Biol; 2002 Nov; 22(22):7802-11. PubMed ID: 12391149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state.
    Bazuine M; Carlotti F; Rabelink MJ; Vellinga J; Hoeben RC; Maassen JA
    Endocrinology; 2005 Apr; 146(4):1818-24. PubMed ID: 15665038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.
    Chi H; Barry SP; Roth RJ; Wu JJ; Jones EA; Bennett AM; Flavell RA
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2274-9. PubMed ID: 16461893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling.
    Wu JJ; Bennett AM
    J Biol Chem; 2005 Apr; 280(16):16461-6. PubMed ID: 15722358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback control of MKP-1 expression by p38.
    Hu JH; Chen T; Zhuang ZH; Kong L; Yu MC; Liu Y; Zang JW; Ge BX
    Cell Signal; 2007 Feb; 19(2):393-400. PubMed ID: 16978838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
    Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
    J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1).
    Wahab N; Cox D; Witherden A; Mason RM
    Biochem J; 2007 Aug; 406(1):131-8. PubMed ID: 17489738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY; Liu Y; Wu GS
    Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.